Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
Add to list
  1. Search results
  2. Cost-consequence analysis of darbepoe...

Cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (QW_EB) in patients with chemotherapy-induced anemia (CIA): The Italian case

G ESPOSITO, M LAMOTTE, Lieven Annemans (UGent) and A BRACCO
(2007) VALUE IN HEALTH. 10(6).
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
ESPOSITO, G., et al. “Cost-Consequence Analysis of Darbepoetin Alfa Administered Every 3 Weeks (Q3W_DA) Compared to Weekly Epoetin Alfa (QW_EA) or Epoetin Beta (QW_EB) in Patients with Chemotherapy-Induced Anemia (CIA): The Italian Case.” VALUE IN HEALTH, vol. 10, no. 6, 2007, p. 324.
APA
ESPOSITO, G., LAMOTTE, M., Annemans, L., & BRACCO, A. (2007). Cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (QW_EB) in patients with chemotherapy-induced anemia (CIA): The Italian case. VALUE IN HEALTH, 10(6), 324.
Chicago author-date
ESPOSITO, G, M LAMOTTE, Lieven Annemans, and A BRACCO. 2007. “Cost-Consequence Analysis of Darbepoetin Alfa Administered Every 3 Weeks (Q3W_DA) Compared to Weekly Epoetin Alfa (QW_EA) or Epoetin Beta (QW_EB) in Patients with Chemotherapy-Induced Anemia (CIA): The Italian Case.” In VALUE IN HEALTH, 10:324.
Chicago author-date (all authors)
ESPOSITO, G, M LAMOTTE, Lieven Annemans, and A BRACCO. 2007. “Cost-Consequence Analysis of Darbepoetin Alfa Administered Every 3 Weeks (Q3W_DA) Compared to Weekly Epoetin Alfa (QW_EA) or Epoetin Beta (QW_EB) in Patients with Chemotherapy-Induced Anemia (CIA): The Italian Case.” In VALUE IN HEALTH, 10:324.
Vancouver
1.
ESPOSITO G, LAMOTTE M, Annemans L, BRACCO A. Cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (QW_EB) in patients with chemotherapy-induced anemia (CIA): The Italian case. In: VALUE IN HEALTH. 2007. p. 324.
IEEE
[1]
G. ESPOSITO, M. LAMOTTE, L. Annemans, and A. BRACCO, “Cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (QW_EB) in patients with chemotherapy-induced anemia (CIA): The Italian case,” in VALUE IN HEALTH, 2007, vol. 10, no. 6, p. 324.
@inproceedings{433764,
  author       = {{ESPOSITO, G and LAMOTTE, M and Annemans, Lieven and BRACCO, A}},
  booktitle    = {{VALUE IN HEALTH}},
  issn         = {{1098-3015}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{A324-A324}},
  title        = {{Cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (QW_EB) in patients with chemotherapy-induced anemia (CIA): The Italian case}},
  volume       = {{10}},
  year         = {{2007}},
}
Web of Science
Times cited: